Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDevelop North Regulatory News (DVNO)

Share Price Information for Develop North (DVNO)

Share Price is delayed by 15 minutes
Get Live Data
75.50    0.00 (0.00%)
Bid:
73.00
Ask:
78.00
Spread: 5.00 (6.849%)
Market Cap: £19.65m
DVNO Live PriceLast checked at - London Stock Exchange

Intraday Develop North Share Chart

Commencement of Share Buyback Programme

13 Nov 2023 07:00

RNS Number : 1563T
Develop North PLC
13 November 2023
Β 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO CANADA, JAPAN, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR THE UNITED STATES OF AMERICA OR TO US PERSONS, OR TO ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

Β 

Β 

For release on 13 November 2023

Β 

DEVELOP NORTH PLC

(the "Company")

Β 

Commencement of Share Buyback Programme

Β 

Β 

The Board of Develop North PLC today announces the commencement of a share buyback programme (the 'programme') whereby the Company will repurchase its Ordinary shares (the 'shares') for up to a maximum consideration of Β£500k. All shares purchased under this programme will be held in treasury.

Β 

The Company has entered into a non-discretionary agreement with Cavendish Capital Markets Limited, acting as principal to conduct the programme and to repurchase shares on the Company's behalf and to make trading decisions under the programme independently of the Company in accordance with agreed parameters.

Β 

The programme will commence today, 13 November 2023, and will end on 31 December 2023. The programme is subject to customary early termination rights.

Β 

The programme will at all times be conducted in accordance with (and within the parameters prescribed by):

1. The Company's general authority to repurchase shares (which authorised the repurchase of a maximum of 4,035,917 shares, being approximately 14.99% of the Company's issued share capital) as approved by shareholders at the Company's AGM on 27 April 2023; and

2. The Market Abuse Regulation (EU) No 596/2014 and the Commission Delegated Regulation (EU) No 2016/1052 (including as each of them forms part of retained EU law in the United Kingdom ('UK') from time to time, including, where relevant, pursuant to the UK's European Union (Withdrawal) Act 2018 and Market Abuse (Amendment) (EU Exit) Regulations 2019) as well as the applicable laws and regulations of the UK Financial Conduct Authority.

Β 

Β 

Β 

For further information regarding Develop North PLC (LEI: 213800EXPWANYN3NEV68) please contact:Β 

Β 

Develop North PLC

Ian McElroy

Β 

+44 (0) 191 222 0099

Tier One Capital Ltd (Investment Adviser)

Brendan O'Grady

+44 (0) 191 222 0099

Apex Fund Administration Services (UK) Limited (Secretary)

Nicola Board

Β 

+44 (0) 1245 398950

Cavendish Capital Markets Limited (Sponsor, Broker and Financial Adviser)

William Marle

+44 (0) 207 220 0500

Β 

Develop North PLC PLC is a closed-end investment company listed on the main market of the London Stock Exchange and specialises in providing finance to the residential and commercial property sector.

Β 

The Company's investment adviser is Newcastle upon Tyne based Tier One Capital Limited. Tier One CapitalΒ is a wealth management and property lending firm providing financial advice services and bespoke tailored lending to the property development market.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCDXBDBDGBDGXG
12
Date   Source Headline
1st Jul 20264:16 pmRNSClosed Period
18th Jun 20267:00 amRNSDividend Declaration
17th Jun 20267:00 amRNSAppointment of Joint Broker
5th May 20261:58 pmRNSTotal Voting Rights
30th Apr 20261:41 pmRNSResult of Annual General Meeting
30th Apr 20261:38 pmRNSNet Asset Value(s)
14th Apr 202612:02 pmRNSChange of Venue for Annual General Meeting
31st Mar 20263:33 pmRNSResult of Equity Issue
24th Mar 20262:45 pmRNSChange of Registered Office
24th Mar 202612:17 pmRNSPublication of a Supplementary Prospectus
12th Mar 20266:20 pmRNSAnnual Financial Report
26th Feb 20262:14 pmRNSDividend Declaration
18th Feb 20262:18 pmRNSGeneral Meeting Result
26th Jan 20267:00 amRNSAppointment of Chief Executive Officer
20th Jan 20262:30 pmRNSChange of Registered Office
16th Jan 202611:12 amRNSRetail Offer
16th Jan 202611:11 amRNSPublication of a Prospectus
14th Jan 20267:00 amRNSNet Asset Value(s)
8th Dec 20259:33 amRNSDividend Declaration
10th Nov 20252:59 pmRNSNet Asset Value(s)
17th Oct 20253:31 pmRNSNon-material change to investment policy
29th Aug 20259:32 amRNSDividend Declaration
11th Aug 20257:00 amRNSHalf-year Report
9th Jul 20257:00 amRNSChange to Investment Policy & Potential Fundraise
4th Jun 20255:52 pmRNSDividend Declaration
2nd May 20257:00 amRNSAppointment of Non-Executive Director
1st May 20255:46 pmRNSResult of Annual General Meeting
1st May 202512:02 pmRNSNet Asset Value(s)
19th Mar 20252:29 pmRNSAnnual Financial Report
12th Mar 20255:24 pmRNSDividend Declaration
21st Nov 20242:35 pmRNSDividend Declaration
21st Nov 20242:31 pmRNSNet Asset Value(s)
30th Aug 20247:00 amRNSDividend Declaration
31st Jul 20242:07 pmRNSNet Asset Value(s)
31st Jul 20242:05 pmRNSHalf-year Report
31st May 202412:55 pmRNSDividend Declaration
1st May 20247:00 amRNSTotal Voting Rights
26th Apr 20247:05 amRNSResult of AGM
26th Apr 20247:00 amRNSNet Asset Value(s)
15th Apr 20241:49 pmRNSTransaction in Own Shares
12th Apr 20245:22 pmRNSTransaction in Own Shares
12th Apr 20244:23 pmRNSTransaction in Own Shares
4th Apr 20249:32 amRNSCommencement of New Share Buyback Programme
26th Mar 20247:00 amRNSAnnual Financial Report
29th Feb 202412:06 pmRNSDividend Declaration
2nd Jan 20249:29 amRNSTotal Voting Rights
21st Dec 20234:55 pmRNSTransaction in Own Shares
18th Dec 20234:45 pmRNSTransaction in Own Shares
13th Dec 20235:03 pmRNSTransaction in Own Shares
8th Dec 20235:01 pmRNSTransaction in Own Shares
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.